🧠
Nootropic Peptides: Cognitive Enhancement & Neuroprotection Research
Nootropic peptides like Selank and Semax have been studied for their potential cognitive-enhancing and neuroprotective properties. Both were developed in Russia and have regulatory approval there, but neither is approved by the FDA. Research suggests these peptides may modulate neurotransmitter systems, with Selank showing anxiolytic properties and Semax demonstrating neuroprotective effects in preclinical models.
2 compounds in this category
Nootropic & Cognitive
SelankTP-7
A synthetic peptide analog of tuftsin, approved in Russia for anxiety and studied for nootropic and immunomodulatory properties.
Moderate EvidenceResearch Only1 studies cited
Nootropic & Cognitive
SemaxMEHFPGP, Heptapeptide ACTH analog
A synthetic peptide analog of ACTH(4-10) approved in Russia as a nootropic, studied for cognitive enhancement and neuroprotection.
Moderate EvidenceResearch Only1 studies cited